On the other hand, Py230 breast cancer-bearing mice receiving the adjuvant chemotherapy (ADR-CYP) starting from 10 days post-tumor induction showed significant reductions in tumor volume (Fig. 2B–D) indicating a therapeutic response of the tumor to the chemotherapy. This evidence concerns the gene PPIG and breast carcinoma.